Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis

作者：Weiting Kang, Zilian Cui, Qianqian Chen, Dong Zhang, Haiyang Zhang, Xunbo Jin · 发表于：Oncotarget · 年份：2016 · DOI：10.18632/oncotarget.13054 · 被引用次数：68 · 研究领域：Bladder and Urothelial Cancer Treatments、Urinary and Genital Oncology Studies、Esophageal Cancer Research and Treatment

// Weiting Kang 1,3,* , Zilian Cui 1,3,* , Qianqian Chen 2,3 , Dong Zhang 1 , Haiyang Zhang 1 and Xunbo Jin 1 1 Minimally Invasive Urology Center, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China 2 Department of Emergency, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China 3 School of Medicine, Shandong University, Jinan, Shandong, China * These authors have contributed equally to this work Correspondence to: Xunbo Jin, email: // Zilian Cui, email: // Keywords : non-muscle invasive bladder cancer; narrow band imaging; white light imaging; resection; recurrence risk Received : August 27, 2016 Accepted : October 27, 2016 Published : November 03, 2016 Abstract Context: Compared with white light imaging (WLI) cystoscopy, narrow band imaging (NBI) cystoscopy could increase the visualization and detection of bladder cancer (BC) at the time of transurethral resection (TUR). NBI cystoscopy could increase the detection of BC, but it remains unclear whether narrow band imaging-assisted transurethral resection (NBI-TUR) could reduce the recurrence risk of non-muscle invasive bladder cancer (NMIBC). Several randomized clinical trials (RCTs) have recently tested the efficacy of NBI-TUR for NMIBC. Objective: To perform a systematic review and meta-analysis of RCTs and evaluate the efficacy of NBI-TUR for NMIBC compared with white light imaging-assisted transurethral resection (WLI-TUR). The end point was recurrence r...